BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Cohance Lifesciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543064
ISIN Demat
INE03QK01018
Book Value (Rs)
115.2528864
NSE Symbol
COHANCE
Divident Yield %
0
Market Cap
(Rs In Cr.)
22,520
P/E (TTM)
60.69
EPS (TTM)
9.7
Face Value
(Rs)
1
Back
Cohance Lifesciences consolidated net profit declines 46.50% in the September 2025 quarter
13-Nov-25   Hrs IST

Net profit of Cohance Lifesciences declined 46.50% to Rs 74.08 crore in the quarter ended September 2025 as against Rs 138.47 crore during the previous quarter ended September 2024. Sales declined 7.98% to Rs 555.57 crore in the quarter ended September 2025 as against Rs 603.77 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales555.57603.77 -8
OPM %21.7734.01 -
PBDT127.79211.95 -40
PBT83.77174.16 -52
NP74.08138.47 -47

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)